Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
22.90
+0.44 (1.96%)
At close: Jun 26, 2026, 4:00 PM EDT
22.70
-0.20 (-0.87%)
After-hours: Jun 26, 2026, 6:58 PM EDT
Nurix Therapeutics Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Nurix Therapeutics stock have an average target of 32.75, with a low estimate of 25 and a high estimate of 45. The average target predicts an increase of 43.01% from the current stock price of 22.90.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nurix Therapeutics stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 10 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 17 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $34 | Buy | Maintains | $34 | +48.47% | Jun 15, 2026 |
| Jefferies | Jefferies | Buy Maintains $45 | Buy | Maintains | $45 | +96.51% | Jun 15, 2026 |
| Needham | Needham | Buy Maintains $34 | Buy | Maintains | $34 | +48.47% | Jun 15, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $32 | Buy | Reiterates | $32 | +39.74% | Jun 10, 2026 |
Financial Forecast
Revenue This Year
142.44M
from 83.98M
Increased by 69.62%
Revenue Next Year
81.63M
from 142.44M
Decreased by -42.70%
EPS This Year
-2.35
from -3.05
EPS Next Year
-2.67
from -2.35
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 821.3M | 217.2M | |
| Avg | 142.4M | 81.6M | |
| Low | 14.5M | 21.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 878.0% | 52.5% | |
| Avg | 69.6% | -42.7% | |
| Low | -82.7% | -85.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.70 | -1.65 | |
| Avg | -2.35 | -2.67 | |
| Low | -3.28 | -3.49 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.